Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
SAN FRANCISCO, Nov. 17, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq:…
NABH INTEGRATES FOGSI’S MATERNAL HEALTH STANDARDS ACROSS ITS CERTIFICATION PROGRAMS
The MoU signed in 2022 has progressed and culminated in the subsumption of…
NABH INTEGRATES FOGSI’S MATERNAL HEALTH STANDARDS ACROSS ITS CERTIFICATION PROGRAMS
The MoU signed in 2022 has progressed and culminated in the subsumption of…
NABH INTEGRATES FOGSI’S MATERNAL HEALTH STANDARDS ACROSS ITS CERTIFICATION PROGRAMS
The MoU signed in 2022 has progressed and culminated in the subsumption of…
NABH INTEGRATES FOGSI’S MATERNAL HEALTH STANDARDS ACROSS ITS CERTIFICATION PROGRAMS
The MoU signed in 2022 has progressed and culminated in the subsumption of…
Hinge Bio Presents Preclinical Data from its GEM-DIMER Programs Targeting B Cell Depletion at the American College of Rheumatology (ACR) Convergence 2024
Hinge Bio’s GEM-DIMER™ platform demonstrates differentiated in vivo and in vitro data…
A2 Bio Highlights Progress of Tmod CAR T-Cell Clinical Programs During 2024 Annual Meeting of the Society for Immunotherapy of Cancer
Oral presentation provides update on enhancements to improve participant diversity and enrollment…
